[90Y]Y-PentixaTher, LysaKare 25 g/25 g solution for infusion, [68Ga]Ga-PentixaFor
PTT101
Phase 2 small_molecule active
Quick answer
[90Y]Y-PentixaTher, LysaKare 25 g/25 g solution for infusion, [68Ga]Ga-PentixaFor for Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary is a Phase 2 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active